Garg Pushkal
SEC insider (Form 3/4/5 filer). CIK 0001829252. EVP Chief R&D at ALNYLAM PHARMACEUTICALS, INC. (ALNY). 154 reported Form 4/5 transactions since Sep 2024; latest on Mar 5, 2026. Located in CAMBRIDGE, MA.
Companies Garg Pushkal has filed insider reports for
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Officer, EVP Chief R&D
Garg Pushkal
CIK: 0001829252
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALNYLAM PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (154 total)
- Mar 5, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect740 shares at avg. $323.55$239K - Mar 5, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect654 shares at avg. $322.33$211K - Mar 5, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect510 shares at avg. $324.59$166K - Mar 5, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect500 shares at avg. $326.08$163K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect215 shares at avg. $320.81$69K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect289 shares at avg. $321.82$93K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect350 shares at avg. $323.01$113K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect106 shares at avg. $319.03$34K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect208 shares at avg. $325.67$68K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect767 shares at avg. $323.84$248K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 5, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 740 | $323.55 | $239,427 | Direct |
| Mar 5, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 654 | $322.33 | $210,804 | Direct |
| Mar 5, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 510 | $324.59 | $165,541 | Direct |
| Mar 5, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 500 | $326.08 | $163,040 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 215 | $320.81 | $68,974 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 289 | $321.82 | $93,006 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 350 | $323.01 | $113,054 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 106 | $319.03 | $33,817 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 208 | $325.67 | $67,739 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 767 | $323.84 | $248,385 | Direct |
1-10 of 154 transactions